Skip to main content
Equibles
ABEO logo

ABEO · Abeona Therapeutics Inc. · Earnings Call Transcripts & Audio

Track ABEO — free

Use ABEO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABEO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.42 -0.07 (-1.19%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$311.94M
Shares
57.18M

Abeona Therapeutics Inc. Earnings Call Transcripts

Quarterly earnings calls for Abeona Therapeutics Inc. (ABEO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $1.00M −$4.10M '22 Q2 22-08-11 ▲250% $3.50M −$16.65M '23 Q2 23-08-08 · $400,000 $108.83M '25 Q2 25-07-02 · $8.72M −$17.07M '26 Q1 26-05-13 LATEST ▲2745% $11.38M −$20.19M '26 Q2 26-08-13
Conference
Investor event
2026-09-16
Abeona Therapeutics Inc. (ABEO) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
Abeona Therapeutics Inc. (ABEO) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
Abeona Therapeutics Inc. (ABEO) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-13
Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call
Revenue
$11.38M
▲ 2745% YoY
Diluted EPS
$-0.35
▼ 120.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Abeona Therapeutics Inc. (ABEO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call Transcript
Confident tone ZivaSkin Commercial Launch Patient Demand and Referrals QTC Activation and Expansion
Revenue
$8.72M
Diluted EPS
$-0.30
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript
Positive tone ZivaSkin launch execution and patient cadence QTC onboarding and site footprint expansion Payor coverage and market access
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript
Positive tone ZivaSkin commercial launch progress Qualified treatment center (QTC) network expansion Patient identification and demand
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-02
Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript
Confident tone ZEVASKYN FDA approval and commercial launch Patient demand and QTC activation Payer coverage and reimbursement
Revenue
$400,000
Diluted EPS
$1.71
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript
Confident tone Patient demand and Abeona Assist ZEVASKYN FDA approval and commercial launch Qualified Treatment Centers and patient activation
Diluted EPS
$-0.24
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call Transcript
Confident tone Launch readiness and qualified treatment centers pz-cel PDUFA and FDA approval PRV (Priority Review Voucher)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Abeona Therapeutics Inc. (ABEO) Q3 2024 Earnings Call
Diluted EPS
$-0.63
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Abeona Therapeutics Inc. (ABEO) Q2 2024 Earnings Call
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2024 Earnings Call
Diluted EPS
$-1.16
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-18
Abeona Therapeutics Inc. (ABEO) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Abeona Therapeutics Inc. (ABEO) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.48
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Abeona Therapeutics Inc. (ABEO) Q2 2023 Earnings Call Transcript
Revenue
$3.50M
▲ 250% YoY
Diluted EPS
$-0.92
▼ 167.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Abeona Therapeutics Inc. (ABEO) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.54
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Abeona Therapeutics Inc. (ABEO) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-08-11
Abeona Therapeutics Inc. (ABEO) Q2 2022 Earnings Call Transcript
Revenue
$1.00M
Diluted EPS
$1.36
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2022 Earnings Call Transcript
Revenue
$346,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-31
Abeona Therapeutics Inc. (ABEO) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Abeona Therapeutics Inc. (ABEO) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Abeona Therapeutics Inc. (ABEO) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-18
Abeona Therapeutics Inc. (ABEO) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-24
Abeona Therapeutics Inc. (ABEO) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Abeona Therapeutics Inc. (ABEO) Q3 2020 Earnings Call Transcript
Revenue
$7.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Abeona Therapeutics Inc. (ABEO) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Abeona Therapeutics Inc. (ABEO) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Abeona Therapeutics Inc. (ABEO) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 earnings calls
Key facts CIK 318306 CUSIP 00289Y206 13F (30d) 68 filings 68 filers Visit website Investor relations